Home / Conferences

Conferences

AAM Annual Meeting – Access! 2020

AAM Annual Meeting – Access! 2020
11–13 May 2020
Washington, DC
USA

DIA 2020 Global Annual Meeting

DIA 2020 Global Annual Meeting
14–18 June 2020
Washington, DC
USA

Medicines for Europe 18th Biosimilar Medicines Conference 2020

18th Biosimilar Medicines Conference 2020
‘Biosimilars: Reshaping the Access Landscape’
1718 September 2020
Hilton Hotel, Apollolaan, Amsterdam
The Netherlands

Medicines for Europe 16th Legal Affairs Conference 2020

16th Legal Affairs Conference 2020
45 November 2020
The Tower Hotel, London
UK

Joint 26th Medicines for Europe and 23rd IGBA Annual Conference 2020

Joint 26th Medicines for Europe and 23rd IGBA Annual Conference 2020
1820 November 2020
Divani Apollon Hotel
Athens, Greece

Microbiological control symposium: consensus on readiness of new methods emerges

A symposium on microbiology in the pharmaceutical sector was the opportunity for the European Directorate for the Quality of Medicines & HealthCare (EDQM) to gather feedback from users of the European Pharmacopoeia on alternative testing methods for microbiological control and sterilisation processes. The event, which took place in Strasbourg on 10−11 October 2017, was attended by a wide range of experts in the pharmaceutical and microbiological fields who reviewed the latest trends and innovations in the field of microbiology, in addition to pharmacopoeial approaches and related regulatory requirements.

European Pharmacopoeia prepares for the future through exchange with stakeholders

To mark the publication of the 9th edition of the European Pharmacopoeia (Ph. Eur.), the EDQM (European Directorate for the Quality of Medicines) organized a large international conference in Tallinn, Estonia, which brought together representatives of European and international regulatory authorities, the World Health Organization (WHO), pharmacopoeias from different continents as well as industry and associations from Europe and beyond. Participants came from 41 different countries, including Brazil, Canada, India, Japan, South Africa, Taiwan and USA.

French generics association promotes biosimilars

French generics association GEMME held its first symposium on the challenges and opportunities associated with biosimilars in France on 3 October 2014.

Topics presented at the 16th IGPA conference on generics

Topics presented at the 16th Annual IGPA Conference, held in Brussels, Belgium, 9–11 December 2013, showed that despite differences in the pharmaceutical market in different countries most appreciate the value of generics. In most cases this is driven by cost reduction.

EGA pushes for increased focus on generics and biosimilars

EGA President Ms Gudbjorg Edda Eggertsdottir, speaking at the European Generic medicines Association’s (EGA’s) conferences in London, UK (11th EGA International Symposium on Biosimilar Medicines) and in Athens, Greece (19th EGA Annual Conference); stressed the importance of keeping generics and biosimilars manufacturers within Europe, thus ensuring that high quality manufacturing jobs and know-how remains in Europe. This would benefit society and patients and increase the competitiveness and innovative capacity of the pharmaceutical industry in Europe.